Kaypeeyes Biotech Profile
Key Indicators
- Authorised Capital ₹ 4.90 M
as on 07-12-2024
- Paid Up Capital ₹ 4.50 M
as on 07-12-2024
- Company Age 31 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.80 M
as on 07-12-2024
- Satisfied Charges ₹ 2.33 M
as on 07-12-2024
- Revenue 17.67%
(FY 2023)
- Profit 23.44%
(FY 2023)
- Ebitda 78.72%
(FY 2023)
- Net Worth 5.17%
(FY 2023)
- Total Assets 5.34%
(FY 2023)
About Kaypeeyes Biotech
The Company is engaged in the Life Sciences Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.90 M and a paid-up capital of Rs 4.50 M.
The company currently has active open charges totaling ₹3.80 M. The company has closed loans amounting to ₹2.33 M, as per Ministry of Corporate Affairs (MCA) records.
Sumathi Bhat and Krishna Kadappu serve as directors at the Company.
- CIN/LLPIN
U24219KA1993PTC014817
- Company No.
014817
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1993
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Mysore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Kaypeeyes Biotech Private Limited offer?
Kaypeeyes Biotech Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Fish Foods, Feed Additives, Flavours & Aromatics, Food Additive, Animal Feed Enzymes, Food Enzymes, Animal Feed, Industrial Chemicals & Supplies, Biocides.
Who are the key members and board of directors at Kaypeeyes Biotech?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Krishna Kadappu  | Managing Director | 20-Oct-1993 | Current |
Board Members(1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sumathi Bhat | Whole-Time Director | 20-Oct-1993 | Current |
Financial Performance of Kaypeeyes Biotech.
Kaypeeyes Biotech Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 17.67% increase. The company also saw a substantial improvement in profitability, with a 23.44% increase in profit. The company's net worth moved up by a moderate rise of 5.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kaypeeyes Biotech?
In 2023, Kaypeeyes Biotech had a public holding of 0.89%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 28 Jan 2022 | ₹1.50 M | Open |
State Bank Of India Creation Date: 19 Nov 2008 | ₹2.30 M | Open |
Others Creation Date: 06 Jan 2017 | ₹0.45 M | Satisfied |
How Many Employees Work at Kaypeeyes Biotech?
Kaypeeyes Biotech has a workforce of 22 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kaypeeyes Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kaypeeyes Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
